Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, it's a great company. But has already had a tremendous run so who knows how much higher it goes from here.
Today's news will eventually be reflected in a higher buyout. Voclosporin will soon be the SOC for LN. Expect more scripts now and more revenue. Great news. Those who shorted Auph to buy Kzr have my sympathy (not).
I wouldn't be worried about Ardx's diarrhea issues. You should work on your own problems regarding your crappy recommendations.
Ardx is a great company. Please stay away from it as whatever you invest in seems to turn to....
One final bit of advice. As your credibility here is gone, you would be well advised to take your disingenuous posts elsewhere and push your other losing stocks on a board where no one knows you yet.
The only thing we know that is truthful about you is that all your posts to buy kzr turned out to be totally wrong and complete rubbish. Therefore you have zero credibility here and despite your claims of success elsewhere (I couldn't care less even if they are true which I doubt) you are the very last person I would listen to for any investment advice. Done and done.
Your track record is really poor so your opinions don't carry much weight. Therefore why would anyone listen to your advice now about anything?
He should have shorted kzr instead of auph lol
The competition gets worse on a red day.
The usual early morning dip. Won't last today if the xbi stays green.
Could not agree more
The regional bank crisis has made clear the mistake Trump made in 2018 by relaxing the regulations for smaller banks that had been put into place after the great financial crisis. Obviously that needs to be addressed and those regulations be reenacted.
The markets don't seem to be too concerned about the regional banks apparently. As I mentioned in my earlier post, the svb crisis will force the fed to reconsider their aggressive rate hikes and I expect the next one will be a quarter instead of a half which is now being widely anticipated by the markets and causing the surge today. The svb crisis will have done all investors a favor by forcing the fed to slow their aggressive hikes and continue the battle against inflation in a more rational and reasoned approach.
On the contrary, the predictions in the post you refer to have come to pass. The government bailed out SVB's depositors, the "contagion" didn't happen, the market didn't crash and yesterday the bio sector finished well after a slow start as expected. The "meltdown" in the regional banks isn't something we need to fret over. It won't result in the kind of systemic failure of the banking system that the svb failure could have if the federal government hadn't stepped in and rectified the situation.
As anticipated, the SVB "crisis" was a storm in a teacup. As mentioned, the early morning selloff today didn't last long. The broader market and the xbi in particular will show gains today, albeit not to the extent that they were taken down Friday. Auph had no exposure to SVB and suffered only as a participant in the bio sector and that is being rectified now. Auph will continue its slow path to profitability and most likely will be acquired at some point.
Yes, the SVB "crisis" has created real opportunity for those with spare cash. Some excellent bios took the hit Friday as the sector went down, and the sale won't last once it becomes clear that the SVB failure was not the start of a much broader selloff.
SVB will be the reason the fed limits its next raise to a quarter instead of a half. The Fed would rather tolerate slower inflation resolution instead of risking a more generalized collapse of the banks. This will precipitate a market rally next week. Monday will also see a plan being initiated to calm investors and prevent further fallout from the SVB incident so I expect the rally will start Monday possibly after an early selloff.
SVB's collapse caused the bios to tank today as a lot of small bios were connected with SVB. We'll see what Monday brings.
Any guesses as to where this is headed? I'm thinking a reverse split is next.
Good script count. BP is watching. Let the buyout rumors resume.
My mistake. Sorry.
Had to laugh at "Benny ramping up the hype". Talk about the pot calling the kettle black.
New patent issued.
Why is srne only 1?
Great catalysts coming this year should see the stock between 8-10 by end of year.. and a good buyout candidate after approval.
This is the Auph board. Take your kzr posts elsewhere. How many times do you need to be reminded?
They're in great shape financially now and without that concern the tutes will load up leading to the approval. I don't think this 15 percent discount will last long, I'd be very surprised if we aren't back over 3 by this time next week or sooner. I think the news going forward should be positive as the FDA now appears to want to approve Xphozah.
Today's shelf registration reflects the company's confidence in getting an approval and puts them in a strong financial position to bring Xphozah to market and fund the trials for the other products. The temporary hit on the sp provides a great price for both new buyers and the rest of us to add shares. Imo, today's news was a positive move and I intend to take advantage of it.
No, we were waiting for you to show up on the first bad day after a great run.
The addressable market for xphozah is 400,000 patients. If we reach half that number (200,000) and the price is the same as it is for IBS-C of about 20k per year, then that's 4 billion per year peak sales. Add in 500 million for the IBS-C indication to give us 4.5 billion per year, almost 8x the current market cap. Mid 20's for a conservative sp and a buyout should be much higher, at 3x peak sales I could see a buyout in the 70's.
I certainly hope you are right but I'm guessing PG is under pressure to sell the company asap. He will make a fortune at 20-25 and obviously could care less about the incredibly loyal shareholders (us).
Absolutely correct. It is easy and very deceptive to cherry pick the data to make it seem like your favorite stock is doing well compared to another. Certainly he is sounding desperate now as it is clear the market believes Voclosporin is the best treatment for LN, not the pretender he is promoting. It won't be long until we are back in double digits but the longer it takes the higher will be the buyout. Before I was thinking 15-20. Now I think 20-25 is likely. Hope the old timers took advantage of the collapse to add to their positions. I know I did.
Voclosporin remains the best treatment by far for LN now and for the foreseeable future. Nothing even comes close and won't for years, if ever. This stock is massively underpriced at 8 but that will most certainly change in the weeks ahead.
How did he "dress this up the best that he could to attract suitors". That post speaks volumes about the poster.
Auph and ardx!
How was the earnings release "cherry picked"? How is your short doing after the $3.44 gain in 10 days?
Talk about a broken record! SoS every post he makes. You really have to wonder why he is so persistent. He's either being paid or extremely nervous about his short or both.
Meant to say being paid overtime
Kiwi would be well advised to cover his short while he can. Might become very expensive for him otherwise very quickly.
Great drug, crappy management but loads of potential. Obviously going to be acquired now that nothing is blocking the sale. Current script counts are meaningless; BP can turn that around very quickly and they will. Just a matter of how badly they want it.